'Carlos Justiniano Ribeiro Chagas', or 'Carlos Chagas' (
pron. ) (born
July 9,
1879,
Oliveira,
Minas Gerais,
Brazil; died
November 8,
1934,
Rio de Janeiro), was a
Brazilian physician. He discovered
Chagas disease, also called ''American trypanosomiasis'' in
1909, while working at the
Oswaldo Cruz Institute in Rio de Janeiro. Chagas’ work is unique in the
history of medicine, because he was the only researcher so far to describe completely a new
infectious disease: its
pathogen,
vector (
Triatominae),
host, clinical manifestations and
epidemiology.
Early life
Chagas was the son of José Justiniano das Chagas, a coffee farmer from Minas Gerais, and Mariana Cândida Chagas. After his secondary studies at
Itu,
São Paulo and
São João del Rei, he enrolled in the School of Mining Engineering at
Ouro Preto, but changed to the Medical School of Rio de Janeiro in 1897, influenced by his uncle, who was a physician and owner of a
hospital at that city. He graduated in 1902 and got his M.D. in the following year with a thesis on the
hematology of
malaria, working at the new medical research institute created by noted physician and, later, friend and colleague,
Oswaldo Cruz (1872-1917).
After a brief stint as a medical practitioner in the hinterlands, Chagas accepted a position in the
port authority of
Santos, São Paulo, with the mission of fighting the malaria epidemic which was affecting its workers. There he introduced an innovation, which consisted in using
pyrethrum, an
insecticide, to disinfect households, with surprising success. His published work on this method served as the basis of
prevention of malaria all over the world and was adopted by a service of the Ministry of Health in Brazil which was established expressly for this purpose.
The discovery of Chagas disease
In 1906, Chagas returned to Rio de Janeiro and joined the
Oswaldo Cruz Institute, where he remained working for the rest of his life. In 1909, he was sent by the Institute to the small city of
Lassance, near the
São Francisco River, to combat a malaria outbreak among the workers of a new
railroad to the city of
Belém in the
Amazon. He stayed there for the next two years and soon was able to observe the peculiar infestation of the rural houses with a large
hematophagous insect of the genus ''
Triatoma'', a kind of "
assassin bug" or "kissing" bug (''barbeiro'' or "barber" in
Portuguese, so called because it sucked the
blood at night by biting the faces of its victims). He discovered that the
intestines of these insects harbored a
flagellate protozoa, a new species of the ''
Trypanosoma'' genre, and was able to prove experimentally that it could be transmitted to
marmoset monkeys which were bitten by the infected bug. Chagas named this new
parasite ''Trypanosoma cruzi''
[ Neue Trypanosomen, Chagas C, , , Vorläufige Mitteilung. Arch. Schiff. Tropenhyg., 1909a ] in honor of Oswaldo Cruz and later that year as ''Schizotrypanum cruzi''
[ Nova tripanozomiase humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem, Chagas C, , , Mem Inst Oswaldo Cruz, 1909b ] and then once again as ''Trypanosoma cruzi''
[ ''Pneumocystis'' and ''Trypanosoma cruzi'': nomenclature and typifications, Redhead SA, Cushion MT, Frenkel JK, Stringer JR, , , J Eukaryot Microbiol, 2006 ].)
Chagas suspected that the parasite could cause human
disease, due to the prevalence of the
insect vector in human households and its habit of biting people, so he took blood samples and, in
April 23,
1909, discovered for the first time the same ''Trypanosoma'' parasite in the blood of a three year-old girl. He also observed parasitic inclusions in the brain and myocardium which would explain some of the clinical manifestations in diseased people and closed the proposed life cycle of the parasite by suggesting that the
armadillo could be its
natural reservoir. To complete his work on the
pathology of the new disease, Chagas described 27 cases of the
acute form of the disease and performed more than 100
autopsies on patients who exhibited the
chronic form.
His description of the new disease was to become a classic in medicine and brought him domestic and international distinction. He was elected to the National Academy of Medicine and received the prestigious
Schaudinn Prize for the best work in
protozoology and
tropical medicine, on June 22, 1912. The contenders were luminaries such as
Paul Ehrlich (1854-1915),
Emile Roux (1853-1933),
Ilya Mechnikov (1845-1916),
Charles Laveran (1845-1922),
Charles Nicolle (1866-1936) and Sir
William Boog Leishman (1865-1926), several of them who had already received or would receive the
Nobel Prize for Medicine. Chagas was twice nominated for the Nobel Prize, in 1913 and 1921, but never received the award.
Chagas was also the first to discover the parasitic fungal genus
''Pneumocystis'' in the lungs of his Trypanosome-experimentally infected animals. At the time he did not recognize it as a separate organism and therefore he described his genus ''Schizotrypanum'' to accommodate both life-cycles that he illustrated beautifully. But, his discovery led others to further investigate and describe ''Pneumocystis'' as a distinct genus, which is now known to be a fungus. Chagas, followed the literature closely and quickly confirmed the distinction, whereupon he again adopted the name ''Trypanosoma cruzi'' that he had originally coined
[. ''Pneumocystis'' is now linked to another disease, PCP or Pneumocystis pneumonia caused by one species (''P. jirovecii'') but the original ''Pneumocystis'' species seen by Chagas in Guinea pigs has not yet been named as a separate species.]
Later life
After the death of his mentor in 1917, Chagas accepted Cruz's directorship of the Institute, a post he held until his death in 1934. From 1920 to 1924 he became the director of the Department of Health in Brazil. Chagas was very active in organizing special health care and prevention services and campaigns for the Spanish flu epidemics, sexually transmitted diseases, leprosy, pediatrics, tuberculosis and rural endemic diseases. He created a nursing school and was the founder of the concept of sanitary medicine, the first chair of tropical medicine and the graduate study of hygiene.
Chagas' discovery was recognized at home and abroad as one of the most important achievements in parasitology. He was twice nominated for the Nobel Prize in Physiology or Medicine (in 1913 and 1921). He never received the award, most probably due to the strong political stance against it by the Brazilian medical establishment at the time.The main Chagas' foe was the Dr. Júlio Afrânio Peixoto , the leader of eugenics in Brazil.Dr. Júlio Afrânio Peixoto had many academical titles and was very fluent, in many foreign languages.Having power and titles, he told a lot of calunies against Carlos Chagas and his great work and nobody in the world got the Noble prize of medicine in 1921.Carlos Chagas was the only real candidate to the prize at that year.
He died in Rio from an acute heart infarction at only 55 years of age.
One of his sons, Dr. Carlos Chagas Filho (1910-2000), became an eminent and internationally recognized scientist in the field of neurophysiology and president of the Pontifical Academy of Sciences. Another son, Evandro Chagas (1905-1940), was also a physician and researcher in tropical medicine, who died accidentally at 35 years of age. His name is honoured by the important biomedical institution Instituto Evandro Chagas, in Belém, state of Pará.
Cited References
General References
★ Lewinsohn R.: Carlos Chagas (1879-1934): the discovery of Trypanosoma cruzi and of American trypanosomiasis (foot-notes to the history of Chagas's disease).''Trans R Soc Trop Med Hyg''. 1979;73(5):513-23.
★ Coutinho M, Freire O Jr, Dias JC. The noble enigma: Chagas' nominations for the Nobel prize. ''Mem Inst Oswaldo Cruz.'' 1999;94 Suppl 1:123-9. Full text
External links
★ Carlos Justiniano Ribeiro Chagas. WhoNamedIt.
★ Dr. Carlos Chagas
★ Historical aspects of Chagas disease. Instituto Oswaldo Cruz.